Literature DB >> 18577477

Ursodeoxycholic acid treatment for patients with postcholecystectomy pain and bile microlithiasis.

Ngozi Okoro1, Amil Patel, Marney Goldstein, Naveen Narahari, Qiang Cai.   

Abstract

BACKGROUND: Microlithiasis has been identified as a cause of idiopathic acute pancreatitis in patients with an intact gallbladder. Microlithiasis has also been identified in the bile of some patients who have undergone cholecystectomy. However, it is unknown whether bile microlithiasis causes postcholecystectomy pain.
OBJECTIVE: To identify bile microlithiasis in patients with postcholecystectomy pain and to investigate the therapeutic effect of ursodeoxycholic acid (urso) on such patients with microlithiasis in the bile.
DESIGN: Prospective randomized trial.
SETTING: Tertiary medical center. PATIENTS: Patients with postcholecystectomy pain and bile crystals.
INTERVENTIONS: Urso treatment. MAIN OUTCOME MEASUREMENTS: The severity and frequency of right upper-quadrant abdominal pain were compared with and without urso treatment, and before and after urso treatment.
RESULTS: A total of 118 patients with postcholecystectomy pain were screened for the study. Twelve patients (10%) were identified with bile crystals. In the first phase, 6 of these patients received urso treatment, whereas the other 6 patients did not receive urso treatment. In the second phase, the latter 6 patients were given the urso treatment. After using urso for a few months, their biliary-type abdominal pain significantly improved or resolved. In the control group, there was no improvement in symptoms. There was a significant difference between the 2 groups (P = .01). LIMITATIONS: Single-center, small number of patients.
CONCLUSIONS: This study provided evidence that supports the hypothesis that bile microlithiasis is indeed a cause for postcholecystectomy pain. Patients with such postcholecystectomy pain may benefit from a microscopic examination of bile for crystals or microlithiasis, and urso treatment if bile crystals are identified.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18577477     DOI: 10.1016/j.gie.2007.09.046

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  7 in total

Review 1.  Acute pancreatitis in pregnancy.

Authors:  Capecomorin S Pitchumoni; Balaji Yegneswaran
Journal:  World J Gastroenterol       Date:  2009-12-07       Impact factor: 5.742

2.  Increased Risk of Acute Pancreatitis with Codeine Use in Patients with a History of Cholecystectomy.

Authors:  Juhyeun Kim; Andrew John Tabner; Graham David Johnson; Babette A Brumback; Abraham Hartzema
Journal:  Dig Dis Sci       Date:  2019-08-29       Impact factor: 3.199

3.  Effects of Rowachol on prevention of postcholecystectomy pain after laparoscopic cholecystectomy: prospective multicenter randomized controlled trial.

Authors:  In Woong Han; O Choel Kwon; Min Gu Oh; Yoo Shin Choi; Seung Eun Lee
Journal:  HPB (Oxford)       Date:  2016-06-30       Impact factor: 3.647

Review 4.  Idiopathic acute pancreatitis: a review on etiology and diagnostic work-up.

Authors:  Giovanna Del Vecchio Blanco; Cristina Gesuale; Marzia Varanese; Giovanni Monteleone; Omero Alessandro Paoluzi
Journal:  Clin J Gastroenterol       Date:  2019-04-30

Review 5.  What have we learned about acute pancreatitis in children?

Authors:  Harrison X Bai; Mark E Lowe; Sohail Z Husain
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-03       Impact factor: 2.839

Review 6.  Translational and clinical perspectives on sphincter of Oddi dysfunction.

Authors:  Kondal Rao Kyanam Kabir Baig; Charles Melbern Wilcox
Journal:  Clin Exp Gastroenterol       Date:  2016-07-28

7.  Long-term patient-reported outcomes following laparoscopic cholecystectomy: A prospective multicenter observational study.

Authors:  In Woong Han; Hyeon Kook Lee; Dae Joon Park; Yoo Shin Choi; Seung Eun Lee; Hongbeom Kim; Wooil Kwon; Jin-Young Jang; Huisong Lee; Jin Seok Heo
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.